WallStreetZenWallStreetZen

NASDAQ: MLYS
Mineralys Therapeutics Inc Stock Ownership - Who owns Mineralys Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mineralys Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adam Scott LevyCFO and Secretary2025-01-13100$9.63
$963.00Sell
Jon CongletonChief Executive Officer2025-01-1318,333$9.06
$166.08kSell
David Malcom RodmanChief Medical Officer2025-01-136,349$1.08
$6.86kBuy
David Malcom RodmanChief Medical Officer2025-01-135,018$0.54
$2.71kBuy
Adam Scott LevyCFO and Secretary2025-01-1310,657$9.09
$96.90kSell
David Malcom RodmanChief Medical Officer2024-12-115,017$0.54
$2.71kBuy
David Malcom RodmanChief Medical Officer2024-11-115,017$0.54
$2.71kBuy
David Malcom RodmanChief Medical Officer2024-11-115,026$1.08
$5.43kBuy
David Malcom RodmanChief Medical Officer2024-11-115,026$15.00
$75.40kSell
David Malcom RodmanChief Medical Officer2024-11-0625,482$1.08
$27.52kBuy

1 of 5

MLYS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MLYS insiders and whales buy or sell their stock.

MLYS Shareholders

What type of owners hold Mineralys Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Brian Taylor Slingsby17.37%8,644,579$82.21MInsider
Catalys Pacific LLC17.37%8,644,579$82.21MInstitution
Srinivas Akkaraju10.20%5,074,916$48.26MInsider
Samsara Biocapital LLC10.20%5,074,916$48.26MInstitution
Samsara Biocapital GP LLC10.20%5,074,916$48.26MInsider
Ra Capital Management LP9.75%4,850,984$46.13MInstitution
Hbm Healthcare Investments Cayman Ltd6.47%3,218,106$30.60MInsider
Ra Capital Management LP6.39%3,178,476$30.23MInsider
Tcg Crossover Management LLC4.96%2,470,265$23.49MInstitution
Blackrock Inc4.31%2,144,168$20.39MInstitution

1 of 3

MLYS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MLYS62.66%37.34%Net SellingNet Selling
PRTC0.01%0.00%
SVRA39.03%60.97%Net SellingNet Selling
RNAC14.51%85.49%Net BuyingNet Buying
TECX15.91%84.09%Net BuyingNet Buying
View Top Biotech Stocks

Mineralys Therapeutics Stock Ownership FAQ

Who owns Mineralys Therapeutics?

Mineralys Therapeutics (NASDAQ: MLYS) is owned by 89.18% institutional shareholders, 53.15% Mineralys Therapeutics insiders, and 0.00% retail investors. Brian Taylor Slingsby is the largest individual Mineralys Therapeutics shareholder, owning 8.64M shares representing 17.37% of the company. Brian Taylor Slingsby's Mineralys Therapeutics shares are currently valued at $83.51M.

If you're new to stock investing, here's how to buy Mineralys Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.